Trending

ankylosing spondylitis

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

Swiss pharma hopes to bounce back from Q1 sales disappointment

X

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

https://pharmaphorum.com/news/novartis-eric-hughes-cosentyx-secukinumab/

Lilly aims for new indication for Taltz

Lilly aims for new indication for Taltz

Eli Lilly is hoping new data from its Taltz (ixekizumab) could give it another potentially lucrative indication and

X

Lilly aims for new indication for Taltz

https://pharmaphorum.com/news/eli-lilly-aims-new-indication-il-17-drug-taltz/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com